Yu Deng

2.2k citations
38 papers · 1.5k indexed · 1 hit paper · h-index 15
Topics
RNA modifications and cancer (8 papers)Cancer-related molecular mechanisms research (7 papers)MicroRNA in disease regulation (6 papers)
Journals
Nature CommunicationsSHILAP Revista de lepidopterologíaAdvanced Functional Materials
Partner nations
China

In The Last Decade

Yu Deng

38 papers receiving 1.4k citations

Hit Papers

Coronavirus disease 2019: What we know?20202026202220242020200400600

Peers

Yu Deng
Comparison fields: 5 of 156
  • Molecular Biology 513
  • Infectious Diseases 347
  • Oncology 325
  • Cancer Research 282
  • Pulmonary and Respiratory Medicine 185
Replace Chang Shu with:
Chang Shu China
Ying Yan China
Yuping Wang China
Yuan Liang China
Xuechen Yu United States
Andrés López‐Cortés Ecuador
Qin Zhou China
Qing Gong China
Xiaofang Zhao China
Jianming Tang China
Yu Deng relative to Chang Shu China Chang Shu's profile →
Citations per field
00.5×1.5×
Chang Shu · 1×
Citations per year

Countries citing papers authored by Yu Deng

Since Specialization
Citations

This map shows the geographic impact of Yu Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Deng more than expected).

Fields of papers citing papers by Yu Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Deng. The network helps show where Yu Deng may publish in the future.

Co-authorship network of co-authors of Yu Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Deng. A scholar is included among the top collaborators of Yu Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Deng. Yu Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 10
3 7
4 3
5 17
6 9
7 18
8 16
9 155
10 6
11 189
12 4
13 43
14 3
15 38
16 25
17 17
18 18
19 11
20 6

About Yu Deng

Yu Deng is a scholar working on Cancer Research, Biological Psychiatry and Pulmonary and Respiratory Medicine, having authored 38 papers that have together received 1.5k indexed citations. Recurring topics across this work include RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (6 papers). The work is most often cited by research in Infectious Diseases (347 citations), Cancer Research (282 citations) and Modeling and Simulation (70 citations). Yu Deng has collaborated with scholars based in China. Frequent co-authors include Feng He, Weina Li, Peng Zhang, Qian Chu, Xiangning Fu, Weina Li, Wei Sun, Yukun Zu, Dandan Lin and Bo Zhong. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Advanced Functional Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026